Overexpression of optineurin E50K disrupts Rab8 interaction and leads to a progressive retinal degeneration in mice.
Glaucoma is one of the leading causes of bilateral blindness affecting nearly 8 million people worldwide. Glaucoma is characterized by a progressive loss of retinal ganglion cells (RGCs) and is often associated with elevated intraocular pressure (IOP). However, patients with normal tension glaucoma (NTG), a subtype of primary open-angle glaucoma (POAG), develop the disease without IOP elevation. The molecular pathways leading to the pathology of NTG and POAG are still unclear. Here, we describe the phenotypic characteristics of transgenic mice overexpressing wild-type (Wt) or mutated optineurin (Optn). Mutations E50K, H486R and Optn with a deletion of the first (amino acids 153-174) or second (amino acids 426-461) leucine zipper were used for overexpression. After 16 months, histological abnormalities were exclusively observed in the retina of E50K mutant mice with loss of RGCs and connecting synapses in the peripheral retina leading to a thinning of the nerve fiber layer at the optic nerve head at normal IOP. E50K mice also showed massive apoptosis and degeneration of entire retina, leading to approximately a 28% reduction of the retina thickness. At the molecular level, introduction of the E50K mutation disrupts the interaction between Optn and Rab8 GTPase, a protein involved in the regulation of vesicle transport from Golgi to plasma membrane. Wt Optn and an active GTP-bound form of Rab8 complex were localized at the Golgi complex. These data suggest that alternation of the Optn sequence can initiate significant retinal degeneration in mice.
Chi
Zai-Long
ZL
National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan.
Akahori
Masakazu
M
Obazawa
Minoru
M
Minami
Masayoshi
M
Noda
Toru
T
Nakaya
Naoki
N
Tomarev
Stanislav
S
Kawase
Kazuhide
K
Yamamoto
Tetsuya
T
Noda
Setsuko
S
Sasaoka
Masaki
M
Shimazaki
Atsushi
A
Takada
Yuichiro
Y
Iwata
Takeshi
T
D019943:Amino Acid Substitution; D000818:Animals; D017209:Apoptosis; D018797:Cell Cycle Proteins; D005136:Eye Proteins / Q000235:genetics* / Q000378:metabolism*; D005901:Glaucoma / Q000235:genetics*; D026901:Membrane Transport Proteins; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D050505:Mutant Proteins / Q000235:genetics / Q000378:metabolism; D009900:Optic Nerve / Q000473:pathology; D011485:Protein Binding; D012162:Retinal Degeneration / Q000235:genetics*; D012165:Retinal Ganglion Cells / Q000473:pathology; D020691:rab GTP-Binding Proteins / Q000378:metabolism*
D018797:Cell Cycle Proteins; D005136:Eye Proteins; D026901:Membrane Transport Proteins; D050505:Mutant Proteins; C501288:Optn protein, mouse; C521976:Rab8 protein, mouse; D020691:rab GTP-Binding Proteins
J Cell Biol. 2005 Apr 25;169(2):285-95
15837803
J Biol Chem. 2005 Oct 14;280(41):34840-8
16091361
Hum Mol Genet. 1998 Sep;7(9):1463-74
9700202
Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4359-67
15557444
J Neurosci. 2006 Nov 15;26(46):11903-14
17108164
Science. 1997 Jan 31;275(5300):668-70
9005853
Am J Ophthalmol. 2003 Nov;136(5):904-10
14597044
Br J Ophthalmol. 2006 Mar;90(3):262-7
16488940
Invest Ophthalmol Vis Sci. 1998 May;39(6):951-62
9579474
Am J Pathol. 2006 Dec;169(6):1976-89
17148662
J Cell Biol. 1993 Oct;123(1):35-45
8408203
J Biol Chem. 2006 Jun 9;281(23):16147-56
16569640
Invest Ophthalmol Vis Sci. 2005 Aug;46(8):2816-22
16043855
Genome Res. 2005 May;15(5):710-7
15867431
Br J Ophthalmol. 1996 May;80(5):389-93
8695555
Invest Ophthalmol Vis Sci. 2008 May;49(5):1932-9
18436825
Hum Mol Genet. 1997 Apr;6(4):641-7
9097971
Cell. 2007 Jun 15;129(6):1201-13
17574030
Mol Vis. 2005 Apr 18;11:284-7
15851979
Nature. 2007 Jul 19;448(7151):366-9
17597763
Curr Biol. 2000 Dec 14-28;10(24):1603-6
11137014
Ophthalmology. 2004 Sep;111(9):1641-8
15350316
Invest Ophthalmol Vis Sci. 2003 Sep;44(9):3880-4
12939304
J Cell Biol. 2005 Oct 24;171(2):313-25
16247030
J Glaucoma. 2004 Aug;13(4):299-303
15226658
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1607-14
17389490
Mol Biol Cell. 2001 Aug;12(8):2341-51
11514620
Zhonghua Yi Xue Za Zhi. 2006 Feb 28;86(8):554-9
16681888
Br J Ophthalmol. 2002 Feb;86(2):238-42
11815354
Hum Mol Genet. 2005 Mar 15;14(6):725-33
15677485
Nucleic Acids Res. 2000 May 1;28(9):1986-93
10756201
Mol Biol Cell. 2009 Mar;20(5):1478-92
19144827
Science. 2002 Feb 8;295(5557):1077-9
11834836
J Cell Biol. 2007 Dec 31;179(7):1523-37
18158332
Nat Rev Mol Cell Biol. 2001 Feb;2(2):107-17
11252952
PLoS One. 2009;4(4):e5114
19340308
J Clin Invest. 2007 Jul;117(7):1763-70
17607354
J Glaucoma. 2006 Oct;15(5):358-63
16988596
Genome Res. 2004 Jul;14(7):1324-32
15231748
PLoS Pathog. 2009 Jul;5(7):e1000521
19609363